Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Wildemann

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Pain|March 21, 2020
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort studyHenrik Heitmann, Bernhard Haller, Laura Tiemann, et al.
Ebiomedicine|May 28, 2020
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort studyStefan Bittner, Falk Steffen, Timo Uphaus, et al.
Neurology|August 9, 2013
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patientsNicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Is <i>APOE</i> ε4 associated with cognitive performance in early MS?Sinah Engel, Christiane Graetz, Anke Salmen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohortPhilip Lennart Poser, Barbara Gisevius, Marianne Tokic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Treatment choices and neuropsychological symptoms of a large cohort of early MSOlga von Bismarck, Theresa Dankowski, Björn Ambrosius, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.
Journal of Neurology|December 6, 2018
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)Andreas Johnen, Paul-Christian Bürkner, Nils C Landmeyer, et al.
Therapeutic Advances in Neurological Disorders|September 11, 2023
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohortAnke Salmen, Robert Hoepner, Vinzenz Fleischer, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Pain|March 21, 2020
Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort studyHenrik Heitmann, Bernhard Haller, Laura Tiemann, et al.
Ebiomedicine|May 28, 2020
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort studyStefan Bittner, Falk Steffen, Timo Uphaus, et al.
Neurology|August 9, 2013
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patientsNicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Is <i>APOE</i> ε4 associated with cognitive performance in early MS?Sinah Engel, Christiane Graetz, Anke Salmen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohortPhilip Lennart Poser, Barbara Gisevius, Marianne Tokic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2023
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)Martin W Hümmert, Carlotta Stern, Friedemann Paul, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Treatment choices and neuropsychological symptoms of a large cohort of early MSOlga von Bismarck, Theresa Dankowski, Björn Ambrosius, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)Sarah Passoke, Carlotta Stern, Vivien Häußler, et al.
Journal of Neurology|December 6, 2018
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)Andreas Johnen, Paul-Christian Bürkner, Nils C Landmeyer, et al.
Therapeutic Advances in Neurological Disorders|September 11, 2023
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohortAnke Salmen, Robert Hoepner, Vinzenz Fleischer, et al.
Pageof 21